382 related articles for article (PubMed ID: 10896850)
1. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
[TBL] [Abstract][Full Text] [Related]
2. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
Wang T; Shankar K; Bucci TJ; Warbritton A; Mehendale HM
Toxicol Appl Pharmacol; 2001 May; 173(1):27-37. PubMed ID: 11350212
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
[TBL] [Abstract][Full Text] [Related]
4. Diet restriction enhances compensatory liver tissue repair and survival following administration of lethal dose of thioacetamide.
Ramaiah SK; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 1998 May; 150(1):12-21. PubMed ID: 9630448
[TBL] [Abstract][Full Text] [Related]
5. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
Chanda S; Mangipudy RS; Warbritton A; Bucci TJ; Mehendale HM
Hepatology; 1995 Feb; 21(2):477-86. PubMed ID: 7843722
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in tissue repair permit survival of diet-restricted rats from an acute lethal dose of thioacetamide.
Ramaiah SK; Bucci TJ; Warbritton A; Soni MG; Mehendale HM
Toxicol Sci; 1998 Oct; 45(2):233-41. PubMed ID: 9848130
[TBL] [Abstract][Full Text] [Related]
7. Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide.
Devi SS; Philip BK; Warbritton A; Latendresse JR; Mehendale HM
Toxicology; 2006 Sep; 226(2-3):107-17. PubMed ID: 16901604
[TBL] [Abstract][Full Text] [Related]
8. Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.
Mangipudy RS; Rao PS; Mehendale HM
Environ Health Perspect; 1996 Jul; 104(7):744-9. PubMed ID: 8841760
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of increased liver tissue repair and survival in diet-restricted rats treated with equitoxic doses of thioacetamide.
Apte UM; Limaye PB; Desaiah D; Bucci TJ; Warbritton A; Mehendale HM
Toxicol Sci; 2003 Apr; 72(2):272-82. PubMed ID: 12655029
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in tissue repair upon repeated exposure to thioacetamide.
Mangipudy RS; Mehendale HM
Toxicol Appl Pharmacol; 1998 Apr; 149(2):254-7. PubMed ID: 9571995
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1.
Wang T; Shankar K; Ronis MJ; Mehendale HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):473-9. PubMed ID: 10900221
[TBL] [Abstract][Full Text] [Related]
12. The role of NF-kappaB signaling in impaired liver tissue repair in thioacetamide-treated type 1 diabetic rats.
Devi SS; Mehendale HM
Eur J Pharmacol; 2005 Oct; 523(1-3):127-36. PubMed ID: 16246324
[TBL] [Abstract][Full Text] [Related]
13. Tissue repair response as a function of dose during trichloroethylene hepatotoxicity.
Soni MG; Mangipudy RS; Mumtaz MM; Mehendale HM
Toxicol Sci; 1998 Apr; 42(2):158-65. PubMed ID: 9579028
[TBL] [Abstract][Full Text] [Related]
14. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
Devi SS; Mehendale HM
Toxicol Appl Pharmacol; 2005 Sep; 207(2):89-102. PubMed ID: 15953624
[TBL] [Abstract][Full Text] [Related]
15. Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
Shankar K; Vaidya VS; Wang T; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2003 Apr; 188(2):122-34. PubMed ID: 12691730
[TBL] [Abstract][Full Text] [Related]
16. Tissue repair response as a function of dose in thioacetamide hepatotoxicity.
Mangipudy RS; Chanda S; Mehendale HM
Environ Health Perspect; 1995 Mar; 103(3):260-7. PubMed ID: 7768227
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
18. Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide.
Chilakapati J; Korrapati MC; Hill RA; Warbritton A; Latendresse JR; Mehendale HM
Toxicology; 2007 Feb; 230(2-3):105-16. PubMed ID: 17187915
[TBL] [Abstract][Full Text] [Related]
19. Antimitotic intervention with colchicine alters the outcome of o-DCB-induced hepatotoxicity in Fischer 344 rats.
Kulkarni SG; Warbritton A; Bucci TJ; Mehendale HM
Toxicology; 1997 Jun; 120(2):79-88. PubMed ID: 9184194
[TBL] [Abstract][Full Text] [Related]
20. Stimulated tissue repair prevents lethality in isopropanol-induced potentiation of carbon tetrachloride hepatotoxicity.
Rao PS; Dalu A; Kulkarni SG; Mehendale HM
Toxicol Appl Pharmacol; 1996 Oct; 140(2):235-44. PubMed ID: 8887439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]